Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609. Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027. Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033. Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609.
Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027.
Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.
Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.